Bone marrow inflammatory memory in cardiometabolic disease and inflammatory comorbidities

Cardiovasc Res. 2024 Feb 17;119(18):2801-2812. doi: 10.1093/cvr/cvad003.

Abstract

Cardiometabolic disorders are chief causes of morbidity and mortality, with chronic inflammation playing a crucial role in their pathogenesis. The release of differentiated myeloid cells with elevated pro-inflammatory potential, as a result of maladaptively trained myelopoiesis may be a crucial factor for the perpetuation of inflammation. Several cardiovascular risk factors, including sedentary lifestyle, unhealthy diet, hypercholesterolemia, and hyperglycemia, may modulate bone marrow hematopoietic progenitors, causing sustained functional changes that favour chronic metabolic and vascular inflammation. In the present review, we summarize recent studies that support the function of long-term inflammatory memory in progenitors of the bone marrow for the development and progression of cardiometabolic disease and related inflammatory comorbidities, including periodontitis and arthritis. We also discuss how maladaptive myelopoiesis associated with the presence of mutated hematopoietic clones, as present in clonal hematopoiesis, may accelerate atherosclerosis via increased inflammation.

Keywords: cardiovascular risk; clonal hematopoiesis; hematopoietic stem and progenitor cells; trained immunity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis* / pathology
  • Bone Marrow* / metabolism
  • Bone Marrow* / pathology
  • Hematopoiesis
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Inflammation / metabolism
  • Myelopoiesis